<?xml version="1.0" encoding="UTF-8"?>
<p>It is assumed that the optimal outcome and ‘clear-cut diagnostic gold standard’ might depend upon the development of hybrid assays in order to minimize the fraction of false negative results. The enhanced RT-qPCR test combined with serological immunoassays (either antibody-detecting or antigen-detecting), would bring an additional diagnostic value for accurate and quick COVID-19 diagnosis in vitro diagnostics, when the human body reacts to an infectious bio-stimulant [
 <xref rid="B21-diagnostics-10-00434" ref-type="bibr">21</xref>].
</p>
